Home / News / India News / Article /
Govt awaits proof on cough syrup-Gambia deaths link
Updated On: 07 October, 2022 08:55 AM IST | New Delhi | Agencies
Maiden Pharma, which manufactures the cough syrup blamed for deaths in West African country by the WHO, says they don’t sell anything in India
Listen to this article :
The factory of Maiden Pharmaceuticals in Sonepat, Haryana. Pic/PTI
India is awaiting more information from the World Health Organization on any links between an Indian-made cough syrup and the deaths of dozens of children in Gambia, two Indian officials said on Thursday. The death of 66 children in the West African country is a blow to India’s image as a “pharmacy of the world” that supplies medicines to all continents, especially Africa. New Delhi-based Maiden Pharmaceuticals made the cough syrup, the WHO said.
“Urgent investigation in the matter has been already taken up...,” said one of two staff members who spoke to Reuters on behalf of the health ministry, but did not want to be identified. “While all required steps will be taken in the matter”, India was awaiting a report establishing “causal relation to death with the medical products in question” and other details from the WHO.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT